Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Oct 20 424B4 Prospectus supplement with pricing info
- 2 Oct 20 EFFECT Notice of effectiveness
-
28 Sep 20 S-1/A IPO registration (amended)
- 10 Sep 20 S-1 IPO registration
CCCC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
C4 Therapeutics, Inc.:
We consent to the use of our report dated August 5, 2020, except as to Note 13, which is as of September 28, 2020, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
September 28, 2020